Avanafil Metabolite M16
Avanafil is a new phosphodiesterase type 5 (PDE5) inhibitor approved to treat erectile dysfunction.
| Catalog Number | CS-O-11892 |
| Alternative Name(s) | 3-((4-((3-chloro-4-methoxybenzyl)amino)-5-((pyrimidin-2-ylmethyl)carbamoyl)pyrimidin-2-yl)(hydroxymethyl)amino)propanoic acid;3-((4-((3-chloro-4-methoxybenzyl)amino)-5-((pyrimidin-2-ylmethyl)carbamoyl)pyrimidin-2-yl)(hydroxymethyl)amino)propanoic acid |
| Research Area | Metabolites |
| Molecular Formula | C23H26ClN7O5 |
| Purity | >98% |
| SMILES | OCC(CCC(O)=O)NC1=NC=C(C(NCC2=NC=CC=N2)=O)C(NCC3=CC(Cl)=C(OC)C=C3)=N1 |
| Size | 500 g |
| Supplier Page | https://www.clearsynth.com/en/CSO11892.html |